In an excerpt from his recent book The War on Ivermectin, Dr. Pierre Kory recalls the first time he and Dr. Paul Marik met, and how the two FLCCC Co-founders “disrupted” an underhanded academic ambush on Dr. Marik’s Vitamin C Sepsis research at a medical conference in early 2020.
“Feck, feck, feck,” Paul yelled. (That’s how Paul sounds when he curses in his South African accent).“It’s negative!”
“What?” I asked.
“It’s fecking negative!”
“What do you mean? How the hell can it be negative?”
“I don’t know,” Paul bellowed. “I just got the paper and I’m already at the airport. Those bastards purposely didn’t send it to me on time!”
“I need to see it,” I insisted.
“I’m not supposed to share it, it’s embargoed until Thursday.”
“F*** that, Paul!” Now I was yelling, too. “Send it to me. I have to see it. It’s negative for everything?”
“Everything.”
“Even the time on vasopressors?”
“Yes.”
“Mortality and length of stay?”
“Yes.”
“Paul, they did something stupid. We know it works, there’s no way the study could be negative. It’s not possible!”
Paul’s reaction was more than justified. He had just learned that the world’s first large, prospective, multi-center, double-blind randomized controlled trial on the impacts of high-dose intravenous Vitamin C (IVC) in septic shock was negative—meaning that the trial concluded it had no impact on any important outcome in the patients treated.
Paul and I both knew that this was utter BS. Paul Marik isn’t just an accomplished physician and researcher, or a former tenured professor of medicine, or the author of hundreds of peer-reviewed journal articles and four critical care textbooks. Paul is also an IVC expert, renowned for developing a lifesaving protocol used to treat sepsis, a condition that causes more than 250,000 deaths per year in the U.S. alone, and according to research published in 2020, is the leading cause of death worldwide—above cancer and cardiovascular disease.
That conversation happened on January 16, 2020, before the words “Covid-19” and “pandemic” were staples in the global vocabulary.
Paul was on his way to an international conference in Belfast, Ireland, called Critical Care Reviews, which would feature an unveiling of the results of the previous year’s most important trials in ICU medicine. There were a lot of eyes on this conference because the medical world was anxiously awaiting the results of the first randomized controlled trial of IVC in sepsis, moderated by the great Paul Marik. It was also going to be the first time Paul and I met in person after spending countless hours on the phone as friends and colleagues over the prior two years. We had no idea that this conference would be consequential for entirely different reasons than we had anticipated. It has taken the painful clarity of hindsight to realize how naive and ignorant we were then, at least in regards to the academic medical system—one we had been practicing, researching, and teaching in for decades.
We had no idea that the events about to unfold over the next two days would be the start of what has turned into a relentless three year battle with a medical system we’ve since discovered has been completely corrupted and captured by the pharmaceutical industry.
The following clip from the HighWire details the “disruption” of what happened next.
